Clinical Trials Directory

Trials / Completed

CompletedNCT02295267

Molecular Analysis of IgE Antibodies in Walnut Allergic Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
1 Year – 70 Years
Healthy volunteers
Accepted

Summary

Accurate diagnosis of food allergy depends on the identification of the causative allergenic molecule(s). The proposed study intends to investigate and compare the pattern of IgE antibody sensitisation in walnut allergic subjects from three different regions of Europe (south (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of novel allergen reagents.

Detailed description

Accurate diagnosis of food allergy depends on the identification of the causative allergenic molecule(s). Thus, full characterization of the major allergens of walnut and their clinical importance is an important undertaking. The proposed study intends to investigate and compare the pattern of IgE antibody sensitisation in walnut allergic subjects from three different regions of Europe (south (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of novel allergen reagents. With a view towards improved in vitro diagnostic methods, we intend to evaluate the diagnostic potential of recombinant walnut allergens in patients with walnut allergy confirmed by a positive provocation or supported by a convincing history of anaphylactic reaction(s) to walnut in the past, patients with pollinosis but no symptoms of walnut allergy and non-atopic control subjects.

Conditions

Interventions

TypeNameDescription
OTHERwalnut allergy provocationdouble blind placebo controlled food challenge

Timeline

Start date
2012-12-01
Primary completion
2017-01-01
Completion
2017-03-01
First posted
2014-11-20
Last updated
2017-05-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02295267. Inclusion in this directory is not an endorsement.